Suppr超能文献

内皮型一氧化氮合酶的动态调节:双重酰化与小窝蛋白相互作用的互补作用

Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.

作者信息

Feron O, Michel J B, Sase K, Michel T

机构信息

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

出版信息

Biochemistry. 1998 Jan 6;37(1):193-200. doi: 10.1021/bi972307p.

Abstract

N-Terminal myristoylation and thiopalmitoylation of the endothelial isoform of nitric oxide synthase (eNOS) are required for targeting the enzyme to specialized signal-transducing microdomains of plasma membrane termed caveolae. We have previously documented that the subcellular localization of eNOS is dynamically regulated by agonists such as bradykinin, which promotes enzyme depalmitoylation and translocation from caveolae. More recently, we have shown that association of eNOS with caveolin, the principal structural protein in caveolae, leads to enzyme inhibition, in a reversible process modulated by Ca2+-calmodulin (CaM). We now report studies of the respective roles of acylation and caveolin interaction for regulating eNOS activity. Using eNOS truncation and deletion mutants expressed in COS-7 cells, we have identified an obligatory role for the N-terminal half of eNOS in stabilizing its association with caveolin. By exploring the differential effects of detergents (CHAPS vs octyl glucoside), we have shown that this direct interaction between both proteins is facilitated by, but does not require, eNOS acylation, and, importantly, that treatment of intact aortic endothelial cells with the calcium ionophore A23187 leads to the rapid disruption of the eNOS-caveolin complexes. Finally, using transiently transfected COS-7 cells, we have observed that the myristoylation-deficient cytosol-restricted eNOS mutant (myr-) as well as the cytosolic fraction of the palmitoylation-deficient eNOS mutant (palm-) may both interact with caveolin; this association also leads to a marked inhibition of enzyme activity, which is completely reversed by addition of calmodulin. We conclude that the regulatory eNOS-caveolin association is independent of the state of eNOS acylation, indicating that agonist-evoked Ca2+/CaM-dependent disruption of the caveolin-eNOS complex, rather than agonist-promoted depalmitoylation of eNOS, relieves caveolin's tonic inhibition of enzyme activity. We therefore propose that caveolin may serve as an eNOS chaperone regulating NO production independently of the enzyme's residence within caveolae or its state of acylation.

摘要

一氧化氮合酶(eNOS)的内皮型同工酶的N端肉豆蔻酰化和硫代棕榈酰化是将该酶靶向到质膜上称为小窝的特殊信号转导微区所必需的。我们之前已经证明,eNOS的亚细胞定位受诸如缓激肽等激动剂的动态调节,缓激肽可促进酶的去棕榈酰化并使其从小窝中转运出来。最近,我们发现eNOS与小窝中的主要结构蛋白小窝蛋白的结合会导致酶的抑制,这是一个由Ca2 + -钙调蛋白(CaM)调节的可逆过程。我们现在报告关于酰化和小窝蛋白相互作用在调节eNOS活性方面各自作用的研究。利用在COS-7细胞中表达的eNOS截短和缺失突变体,我们确定了eNOS N端的一半在稳定其与小窝蛋白的结合中起必要作用。通过探究去污剂(CHAPS与辛基葡糖苷)的不同作用,我们表明这两种蛋白质之间的直接相互作用虽受eNOS酰化促进,但并非必需,并且重要的是,用钙离子载体A23187处理完整的主动脉内皮细胞会导致eNOS - 小窝蛋白复合物迅速解离。最后,利用瞬时转染的COS-7细胞,我们观察到肉豆蔻酰化缺陷的胞质受限eNOS突变体(myr-)以及棕榈酰化缺陷的eNOS突变体(palm-)的胞质部分都可能与小窝蛋白相互作用;这种结合也会导致酶活性受到显著抑制,而添加钙调蛋白可完全逆转这种抑制。我们得出结论,调节性的eNOS - 小窝蛋白结合独立于eNOS的酰化状态,这表明激动剂诱发的Ca2 + / CaM依赖性小窝蛋白 - eNOS复合物的解离,而非激动剂促进的eNOS去棕榈酰化,解除了小窝蛋白对酶活性的持续性抑制。因此,我们提出小窝蛋白可能作为一种eNOS伴侣蛋白,独立于该酶在小窝中的定位或其酰化状态来调节NO的产生。

相似文献

3
The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Cardiovasc Res. 2006 Aug 1;71(3):478-85. doi: 10.1016/j.cardiores.2006.04.013. Epub 2006 Apr 27.
5
Targeting and translocation of endothelial nitric oxide synthase.
Braz J Med Biol Res. 1999 Nov;32(11):1361-6. doi: 10.1590/s0100-879x1999001100006.
9
Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase.
J Biol Chem. 1997 Oct 10;272(41):25907-12. doi: 10.1074/jbc.272.41.25907.

引用本文的文献

1
Protein lipidation in the tumor microenvironment: enzymology, signaling pathways, and therapeutics.
Mol Cancer. 2025 May 7;24(1):138. doi: 10.1186/s12943-025-02309-7.
2
Subcellular Localization Guides eNOS Function.
Int J Mol Sci. 2024 Dec 13;25(24):13402. doi: 10.3390/ijms252413402.
3
Generation of nanoscopic membrane curvature for membrane trafficking.
Nat Rev Mol Cell Biol. 2023 Jan;24(1):63-78. doi: 10.1038/s41580-022-00511-9. Epub 2022 Aug 2.
4
Critical Role of Caveolin-1 Loss/Dysfunction in Pulmonary Hypertension.
Med Sci (Basel). 2021 Sep 22;9(4):58. doi: 10.3390/medsci9040058.
5
Heterogeneous effect of aging on vasorelaxation responses in large and small arteries.
Physiol Rep. 2020 Jan;8(1):e14341. doi: 10.14814/phy2.14341.
6
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation.
Physiol Rev. 2019 Jan 1;99(1):311-379. doi: 10.1152/physrev.00036.2017.
7
Nitric oxide signalling in cardiovascular health and disease.
Nat Rev Cardiol. 2018 May;15(5):292-316. doi: 10.1038/nrcardio.2017.224. Epub 2018 Feb 1.
8
Nitric oxide donor [Ru(terpy)(bdq)NO] induces uncoupling and phosphorylation of endothelial nitric oxide synthase promoting oxidant production.
Free Radic Biol Med. 2017 Nov;112:587-596. doi: 10.1016/j.freeradbiomed.2017.09.004. Epub 2017 Sep 9.
9
The Molecular Basis of Portal Hypertension.
Trans Am Clin Climatol Assoc. 2017;128:330-345.
10
Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases.
Oxid Med Cell Longev. 2016;2016:7364138. doi: 10.1155/2016/7364138. Epub 2016 Aug 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验